Company Overview
Bugs Bioscience Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Tuesday 25 February 2014, so this is a well established company. Bugs Bioscience Limited has been in business for 12 years and 1 month. The accounts status is total exemption full and the accounts are next due on Monday 30 November 2026.
Registered Address

2 Royal College Street, London Bioscience Innovation Centre, London, NW1 0NH
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameBUGS BIOSCIENCE LIMITED
Company Number08911333
Registered Office Address2 Royal College Street
 London Bioscience Innovation Centre
 NW1 0NH
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date25/02/2014
Accounting Reference Date Day28
Accounting Reference Date Month2
Accounts Next Due Date30/11/2026
Accounts Last Made Up Date28/02/2025
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date25/03/2017
Returns Last Made Up Date25/02/2016
Previous Company NameChanged Date
FRIARS 703 LIMITED29 Apr 2014
Directors & Members
Show Resigned
Mark Cranmer - Director
(British, 46 years old, born July 1980)
Appointed 09 May 2018
 Active
Jason Hinds - Director
(British, 56 years old, born September 1970)
Appointed 04 April 2014
 Active
Graham Snudden - Director
(British, 63 years old, born August 1963)
Appointed 04 April 2014
 Active
Secretaries
Show Resigned
Graham Snudden - Secretary
Appointed 22 April 2015
 Active
Other Company Directorships
Mark Cranmer
No companies found
Jason Hinds
No companies found
Graham Snudden
BLUEGNOME LIMITED
IGENOMIX UK LTD
INTELLEGENS LIMITED
NONACUS LIMITED
PILGRIMAGE PEOPLE LTD
SURE LABORATORIES LIMITED
Balance Sheet Unlock full report
Accounts Date 28-Feb-2025 28-Feb-2023 28-Feb-2022
Balance Sheet
Fixed Assets 0 0 0
Current Assets 108,572 108,572 253,808
Creditors Due Within One Year 45,975 45,975 115,081
Working Cap 62,597 62,597 138,727
Total Assets Less Current Liabilities 62,597 62,597 138,727
Long-term Liabilities 0 0 0
Net Assets 62,597 62,597 138,727
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 62,597 62,597 138,727
Common Size Financial Analysis Unlock full report
Accounts Date 28-Feb-2025 28-Feb-2023 28-Feb-2022
Tangible Fixed Assets - - -
Fixed Assets 0.0% 0.0% 0.0%
Stocks Inventory - - -
Debtors 25.1% 25.1% 24.6%
Cash Bank In Hand 74.9% 74.9% 63.6%
Current Assets 100.0% 100.0% 100.0%
Creditors Due Within One Year 42.3% 42.3% 45.3%
Net Current Assets Liabilities 57.7% 57.7% 54.7%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 57.7% 57.7% 54.7%
Capital Employed - - -
Total Assets Less Current Liabilities 57.7% 57.7% 54.7%
Financial Ratio Analysis Unlock full report
Accounts Date 28-Feb-2025 28-Feb-2023 28-Feb-2022
Liquidity Ratio 2.4 2.4 2.2
Solvency Ratio 2.4 2.4 2.2
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 28-Feb-2025 28-Feb-2023 28-Feb-2022
Assets 108,572 108,572 253,808
Debt 45,975 45,975 115,081
Net Assets/Debt 62,597 62,597 138,727

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet presents modest net assets. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NW1 0NH
CONVENTION ASSOCIATES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR DIAGNOSTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR SERVICES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR THERAPEUTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR LIMITED
THE LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
ABACO CAPITAL PLC
Rsm Restructuring Advisory Llp Central Square 5th Floor, 29 Wellington Street, Leeds, NW1 0NH
LEUCID BIO LTD
BUILDING 1000 BEACH DRIVE, WATERBEACH, CAMBRIDGE, NW1 0NH
BIO2BUSINESS LIMITED
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
DELTADOT LIMITED
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
NANOREGMED LTD
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Document Filings
Confirmation statement made on 5 February 2026 with no updates
Confirmation statement made on 25 February 2025 with no updates
Confirmation statement made on 25 February 2024 with no updates
Change of details for Mr Graham Robert Snudden as a person with significant control on 31 July 2023
Notification of St George's Hospital Medical School as a person with significant control on 25 July 2023
Notification of Jason Hinds as a person with significant control on 25 July 2023
Confirmation statement made on 25 February 2023 with no updates
Confirmation statement made on 25 February 2022 with updates
Confirmation statement made on 25 February 2021 with no updates
Confirmation statement made on 25 February 2020 with no updates
Confirmation statement made on 25 February 2019 with no updates
Appointment of Mr Mark Cranmer as a director on 9 May 2018
Termination of appointment of Andrew Joseph Barber as a director on 30 April 2018
Confirmation statement made on 25 February 2018 with no updates
Appointment of Dr Andrew Barber as a director on 1 July 2017
Termination of appointment of Nicola Jane Arnold as a director on 30 June 2017
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free